Bristol Myers Squibb’s Abecma recommended for EU approval

The EMA CHMP has recommended marketing authorisation for Bristol Myers Squibb’s Abecma for multiple myeloma.

Jan 29, 2024 - 18:00

Bristol Myers Squibb’s Abecma recommended for EU approval

The EMA CHMP has recommended marketing authorisation for Bristol Myers Squibb’s Abecma for multiple myeloma.

Read the original article

Tags:

Previous Article

Celltrion USA seeks FDA approval for CT-P47 biosimilar

‘Seismic shift’ to crowdsourced scientific data presents promising, complex oppo...

What's Your Reaction?

0

Like

0

Dislike

0

Love

0

Funny

0

Angry

0

Sad

0

Wow

Related Posts

STAT+: Federal judge rules against AstraZeneca in lawsuit challenging Medicare drug price negotiation

STAT+: Federal judge rules against AstraZeneca in lawsu...

Mar 2, 2024

FDA issues CRL to Orexo’s NDA for opioid overdose medication

FDA issues CRL to Orexo’s NDA for opioid overdose medic...

Jul 18, 2024

STAT+: Pharmalittle: Novo halts Ozempic kidney failure trial after early signs of success; GSK settles California Zantac lawsuit

STAT+: Pharmalittle: Novo halts Ozempic kidney failure ...

Oct 12, 2023